Comprehensive analysis of MAPK genes in the prognosis, immune characteristics, and drug treatment of renal clear cell carcinoma using bioinformatic analysis and Mendelian randomization

MAPK/ERK通路 肾透明细胞癌 肾细胞癌 基因 免疫系统 免疫疗法 表观遗传学 生物 肿瘤科 医学 癌症研究 激酶 遗传学 免疫学
作者
Xinyi Zheng,Yiqiu Wang,Xiaoyan Qiu
出处
期刊:European Journal of Pharmacology [Elsevier BV]
卷期号:980: 176840-176840 被引量:1
标识
DOI:10.1016/j.ejphar.2024.176840
摘要

Mitogen-activated protein kinase (MAPK) signalling is vitally important in tumour development and progression. This study is the first to comprehensively analyse the role of MAPK-family genes in the progression, prognosis, immune-cell infiltration, methylation, and potential therapeutic value drug candidates in ccRCC. We identified a novel prognostic panel of six MAPK-signature genes (MAP3K12, MAP3K1, MAP3K5, MAPK1, MAPK8, MAPK9), and introduced a robust MAPK-signature risk model for predicting ccRCC prognosis. Model construction, evaluation, and external validation using datasets from the Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) database demonstrated its stability, as well as high sensitivity and specificity. Enrichment analysis suggested the participation of immune-mediated mechanism in MAPK dysregulation in ccRCC. Immune-infiltration analysis confirmed the relationship and revealed that the MAPK-signature risk model might stratify immunotherapy response in ccRCC, which was verified in drug sensitivity analysis and validated in external ccRCC immunotherapy dataset (GSE67501). Potential therapeutic drug predictions for key MAPKs using DSigDB, Network Analyst, CTD, and DGIdb were subsequently verified by molecular docking with AutoDock Vina and PyMol. Mendelian randomization further demonstrated the possibilities of the MAPK-signature genes as targets for therapeutic drugs in ccRCC. Methylation analysis using UALCAN and MethSurv revealed the participation of epigenetic modifications in dysregulation and survival difference of MAPK pathway in ccRCC. Among the key MAPKs, MAP3K12 exhibited the highest significance, indicating its independent prognostic value as single gene in ccRCC. Knockout and overexpression validation experiments in vitro and in vivo found that MAP3K12 acted as a promoter of tumour progression in RCC, suggesting a pivotal role for MAP3K12 in the proliferation, migration, and invasion of RCC cells. Our findings proposed the potential of MAPK-signature genes as biomarkers for prognosis and therapy response, as well as targets for therapeutic drugs in ccRCC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
呆呆完成签到 ,获得积分10
刚刚
纯真雁菱完成签到,获得积分10
3秒前
xuhanghang完成签到,获得积分10
6秒前
hhh完成签到,获得积分10
7秒前
皮皮蛙完成签到,获得积分10
8秒前
鸡蛋完成签到 ,获得积分10
12秒前
Xiaoxiao应助科研通管家采纳,获得10
12秒前
Xiaoxiao应助科研通管家采纳,获得10
12秒前
玩命的十三完成签到 ,获得积分10
13秒前
眰恦完成签到 ,获得积分10
14秒前
HY完成签到,获得积分10
14秒前
yulian完成签到,获得积分10
16秒前
16秒前
无与伦比完成签到 ,获得积分10
17秒前
独行者完成签到,获得积分10
19秒前
20秒前
蓝桉完成签到 ,获得积分10
20秒前
Yue完成签到 ,获得积分10
25秒前
GB完成签到 ,获得积分10
26秒前
长风与海浪完成签到 ,获得积分10
27秒前
无为完成签到 ,获得积分10
29秒前
Zo完成签到,获得积分10
30秒前
iwsaml完成签到 ,获得积分10
30秒前
SciEngineerX完成签到,获得积分10
31秒前
31秒前
不吃芹菜完成签到,获得积分0
32秒前
曾经小伙完成签到 ,获得积分10
32秒前
YANGMJ完成签到,获得积分10
33秒前
小杨完成签到,获得积分10
36秒前
37秒前
wu8577完成签到 ,获得积分10
41秒前
愛愛愛愛发布了新的文献求助10
42秒前
42秒前
kk完成签到,获得积分10
45秒前
sally发布了新的文献求助10
46秒前
听寒完成签到,获得积分10
47秒前
OhOHOh完成签到,获得积分10
48秒前
专注的翠彤完成签到,获得积分10
49秒前
木木三完成签到,获得积分20
50秒前
乔乔完成签到,获得积分10
52秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Immigrant Incorporation in East Asian Democracies 600
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3968578
求助须知:如何正确求助?哪些是违规求助? 3513391
关于积分的说明 11167428
捐赠科研通 3248822
什么是DOI,文献DOI怎么找? 1794499
邀请新用户注册赠送积分活动 875116
科研通“疑难数据库(出版商)”最低求助积分说明 804664